1. Baldwin, W. M., Van Es, A., Valentijn, R. M., Van Gemert, G. W., Daha, M. R., and Vanes, L. A., 1982, Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections, Clin. Exp. Immunol. 50:515–524.
2. Balfour, H. H., Jr., Bean, B., Mitchell, C. D., Sachs, G. W., Boen, J. R., and Edelman, C. K., 1982, Acyclovir in immunocompromised patients with cytomegalovirus disease, Am. J. Med. 73:241–248.
3. Betts, R. F., 1984, The relationship of epidemiology and treatment factors to infection and allograft survival in renal transplantation, in: Pathogenesis and Prevention of Human Cytomegalovirus Infection (S. A. Plotkin, ed.), Alan R. Liss, New York, pp. 87–100.
4. Betts, R. F., and Schmidt, S. G., 1981, Cytolytic IgM antibody to cytomegalovirus in primary cytomegalovirus infection in humans, J. Infect. Dis. 143:821–826.
5. Betts, R. F., Freeman, R. B., Douglas, R. G., Jr., Talley, T. E., and Rundell, B., 1975, Transmission of cytomegalovirus infection with renal allograft, Kidney Int. 8:387–394.